Financhill
Sell
12

NHNCF Quote, Financials, Valuation and Earnings

Last price:
$115.00
Seasonality move :
0%
Day range:
$115.00 - $115.00
52-week range:
$115.00 - $115.00
Dividend yield:
0.81%
P/E ratio:
14.13x
P/S ratio:
2.29x
P/B ratio:
0.91x
Volume:
--
Avg. volume:
--
1-year change:
--
Market cap:
$17.1B
Revenue:
$7.4B
EPS (TTM):
$8.14
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $3.7B $4.5B $6B $6.4B $7.4B
Revenue Growth (YoY) -26.25% 19.68% 33.14% 7.23% 15.87%
 
Cost of Revenues -- -- -- -- --
Gross Profit $3.7B $4.5B $6B $6.4B $7.4B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $1.7B $2.2B $3B $3.5B $4.1B
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $2.7B $3.4B $4.8B $5.4B $6.3B
Operating Income $991.1M $1B $1.2B $1B $1.1B
 
Net Interest Expenses $12M $13.9M $35.4M -- --
EBT. Incl. Unusual Items $1.2B $1.4B $1.9B $842.1M $1.1B
Earnings of Discontinued Ops. -$449.5M -$249.7M $13.1B -- --
Income Tax Expense $403.8M $415.4M $566.7M $319M $379.9M
Net Income to Company $340.5M $712.7M $14.4B $523.1M $753.8M
 
Minority Interest in Earnings $159.8M $132.5M $10.7M $67.7M $20.9M
Net Income to Common Excl Extra Items $500.3M $845.2M $14.4B $590.7M $774.7M
 
Basic EPS (Cont. Ops) $3.44 $5.80 $88.11 $3.89 $5.10
Diluted EPS (Cont. Ops) $3.44 $5.76 $88.11 $3.87 $5.03
Weighted Average Basic Share $145.5M $145.7M $163.5M $151.8M $152M
Weighted Average Diluted Share $145.5M $146.7M $150.1M $152.5M $153.9M
 
EBITDA $1.6B $1.8B $2.3B $1.3B $1.7B
EBIT $1.2B $1.4B $1.9B $897.8M $1.2B
 
Revenue (Reported) $3.7B $4.5B $6B $6.4B $7.4B
Operating Income (Reported) $991.1M $1B $1.2B $1B $1.1B
Operating Income (Adjusted) $1.2B $1.4B $1.9B $897.8M $1.2B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $1.1B $1.5B $1.5B $1.9B $2B
Revenue Growth (YoY) 24.81% 30.14% 3.13% 21.17% 7.63%
 
Cost of Revenues -- -- -- -- --
Gross Profit $1.1B $1.5B $1.5B $1.9B $2B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $899M $1.2B $1.3B $1.6B $1.6B
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $899M $1.2B $1.3B $1.6B $1.6B
Operating Income $245.3M $301.6M $246.5M $289.3M $387.4M
 
Net Interest Expenses -- -- -- -- $10.8M
EBT. Incl. Unusual Items $304.1M $426.8M $279.7M $384M $481.8M
Earnings of Discontinued Ops. -$7.3M -- -- -- --
Income Tax Expense $98.9M $148.6M $106.9M $112.9M $90.9M
Net Income to Company $202.8M -$179.8M $158.4M $271.3M $398.6M
 
Minority Interest in Earnings $8.5M $7.9M $19M $14.9M -$7.2M
Net Income to Common Excl Extra Items $206.4M $286.2M $191.8M $286M $383.8M
 
Basic EPS (Cont. Ops) $1.42 $1.92 $1.27 $1.89 $2.52
Diluted EPS (Cont. Ops) $1.42 $1.90 $1.26 $1.87 $2.50
Weighted Average Basic Share $145.4M $149M $151.3M $151.6M $152M
Weighted Average Diluted Share $145.4M $150.5M $152.1M $152.6M $153.5M
 
EBITDA $245.3M $301.6M $246.5M $289.3M $387.4M
EBIT $245.3M $301.6M $246.5M $289.3M $387.4M
 
Revenue (Reported) $1.1B $1.5B $1.5B $1.9B $2B
Operating Income (Reported) $245.3M $301.6M $246.5M $289.3M $387.4M
Operating Income (Adjusted) $245.3M $301.6M $246.5M $289.3M $387.4M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $4.2B $5.6B $6.3B $7.2B $7.7B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit $4.2B $5.6B $6.3B $7.2B $7.7B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $2.1B $3.2B $3.6B $4.3B $4.2B
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $3.2B $4.5B $5.3B $6.1B $6.4B
Operating Income $976.8M $1.1B $1.1B $1.1B $1.4B
 
Net Interest Expenses -- -- $268.6M $157.7M --
EBT. Incl. Unusual Items $1.3B $1.9B $1.2B $935.3M $1.7B
Earnings of Discontinued Ops. -$285.6M $13.4B -- -- --
Income Tax Expense $435M $480.4M $496.3M $314.7M $374.4M
Net Income to Company $560.3M $14.3B $851.7M $641.4M $1.3B
 
Minority Interest in Earnings $141.4M $28.2M $71.9M $21.9M -$24.9M
Net Income to Common Excl Extra Items $693.7M $14.9B $749.2M $642.5M $1.3B
 
Basic EPS (Cont. Ops) $4.77 $100.73 -$3.66 $4.22 $8.24
Diluted EPS (Cont. Ops) $4.77 $100.44 -$3.68 $4.16 $8.14
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $1.2B $1.5B $1.8B $970.4M $1.5B
EBIT $1.2B $1.5B $1.8B $970.4M $1.5B
 
Revenue (Reported) $4.2B $5.6B $6.3B $7.2B $7.7B
Operating Income (Reported) $976.8M $1.1B $1.1B $1.1B $1.4B
Operating Income (Adjusted) $1.2B $1.5B $1.8B $970.4M $1.5B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $3.2B $4.3B $4.7B $5.5B $5.8B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit $3.2B $4.3B $4.7B $5.5B $5.8B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $2.4B $3.5B $3.9B $4.7B $4.7B
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $2.4B $3.5B $3.9B $4.7B $4.7B
Operating Income $742.4M $859.8M $763.5M $832.3M $1.1B
 
Net Interest Expenses $9.4M -- $39.8M $82.9M $75.2M
EBT. Incl. Unusual Items $893.4M $1.4B $701.4M $795.7M $1.3B
Earnings of Discontinued Ops. -$228.9M $13.5B -- -- --
Income Tax Expense $279.2M $342.5M $277.2M $272.4M $267.9M
Net Income to Company $387.6M $13.9B $404.2M $522.5M $1B
 
Minority Interest in Earnings $96.7M -$7.2M $55.1M $9.4M -$36.5M
Net Income to Common Excl Extra Items $482.1M $14.5B $479.2M $532.7M $1B
 
Basic EPS (Cont. Ops) $3.31 $98.19 $3.16 $3.50 $6.68
Diluted EPS (Cont. Ops) $3.31 $97.94 $3.14 $3.44 $6.58
Weighted Average Basic Share $436.3M $445.2M $455.4M $461.2M $455.7M
Weighted Average Diluted Share $436.3M $448.3M $458.3M $478.9M $462.6M
 
EBITDA $742.4M $859.8M $763.5M $832.3M $1.1B
EBIT $742.4M $859.8M $763.5M $832.3M $1.1B
 
Revenue (Reported) $3.2B $4.3B $4.7B $5.5B $5.8B
Operating Income (Reported) $742.4M $859.8M $763.5M $832.3M $1.1B
Operating Income (Adjusted) $742.4M $859.8M $763.5M $832.3M $1.1B
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $3.2B $1.5B $2.3B $2.2B $2.8B
Short Term Investments $306.9M $1.1B $974.1M $1.6B $1.2B
Accounts Receivable, Net -- -- -- $419.4M $381.3M
Inventory $47.6M $4M $5.2M $6.9M $11.5M
Prepaid Expenses $217.4M $70.1M $100.8M $158.1M $150.2M
Other Current Assets $15.8M $2M $7.6M $8.3M $7.2M
Total Current Assets $4.9B $9.7B $4.6B $5.1B $5.5B
 
Property Plant And Equipment $2B $1.7B $2B $2.5B $2.7B
Long-Term Investments -- -- -- -- --
Goodwill $183.1M $31.4M $521.9M $750.6M $2B
Other Intangibles $111.6M $65M $261.1M $422.7M $673.2M
Other Long-Term Assets $49.9K -- -$516.9K $1.5M $2.9M
Total Assets $10.6B $15.6B $28.3B $26.8B $27.7B
 
Accounts Payable -- -- -- -- --
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations $145.8M $48.9M $88.7M $153.2M $182.1M
Other Current Liabilities $11.4M -- -- -- --
Total Current Liabilities $3.3B $7.3B $3.3B $4.3B $4.9B
 
Long-Term Debt $692.4M $138.2M $2.7B $1.6B $2.1B
Capital Leases -- -- -- -- --
Total Liabilities $5B $8B $8.1B $8.3B $8.9B
 
Common Stock $14.2M $15.1M $13.8M $13.1M $12.8M
Other Common Equity Adj -- -- -- -- --
Common Equity $5B $6.8B $19.8B $18B $18B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $603M $814.2M $413.1M $559.3M $800.8M
Total Equity $5.6B $7.6B $20.2B $18.6B $18.8B
 
Total Liabilities and Equity $10.6B $15.6B $28.3B $26.8B $27.7B
Cash and Short Terms $3.5B $2.6B $3.3B $3.7B $3.9B
Total Debt $1.2B $666.6M $3.1B $2.7B $2.7B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $1.2B $1.5B $2B $2.3B $3.5B
Short Term Investments $1.1B $1.3B $1.1B $1.4B $2.2B
Accounts Receivable, Net -- -- -- -- --
Inventory $2.1M $3.8M $5.4M $9M $19.6M
Prepaid Expenses $10M $4.5M $14.4M $3.8M $21.4M
Other Current Assets $68M $97.5M $139.7M $154.9M $152.6M
Total Current Assets $8.7B $4B $4.2B $5.1B $7.2B
 
Property Plant And Equipment $1.5B $1.9B $2.2B $2.6B $2.6B
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles $83.9M $755.5M $1.1B $2.5B $2.7B
Other Long-Term Assets $35M $43.1M $88.1M $69.7M $66.6M
Total Assets $13.2B $27.7B $24.1B $26.3B $28.5B
 
Accounts Payable -- -- -- -- --
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations $45.3M $67.1M $127.6M $156.6M $168.5M
Other Current Liabilities $1.1B $1.5B $1.6B $2.2B $2.3B
Total Current Liabilities $6.2B $3.3B $3.4B $4.4B $4.5B
 
Long-Term Debt $135.9M $2.3B $1.6B $2B $2.3B
Capital Leases -- -- -- -- --
Total Liabilities $6.9B $7.4B $7.1B $8.7B $8.5B
 
Common Stock $14.1M $13.9M $11.5M $12.2M $12.6M
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $813.8M $395.8M $489.2M $706.1M $1.1B
Total Equity $6.3B $20.4B $17B $17.6B $20B
 
Total Liabilities and Equity $13.2B $27.7B $24.1B $26.3B $28.5B
Cash and Short Terms $2.3B $2.8B $3.1B $3.7B $5.7B
Total Debt $1.3B $3B $2.5B $2.9B $2.6B
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders $340.5M $712.7M $14.4B $523.1M $753.8M
Depreciation & Amoritzation $427.3M $417.7M $378.7M $435.8M $445.6M
Stock-Based Compensation $54.5M $131.3M $216.6M $74.2M $208M
Change in Accounts Receivable -$47.9M -$93.2M -$34.6M -$43.8M $32.7M
Change in Inventories -- -- -- $12.9M -$1.7M
Cash From Operations $1.2B $1.2B $1.2B $1.1B $1.5B
 
Capital Expenditures $439M $730.2M $704M $587.6M $529.8M
Cash Acquisitions -$513.3M -$352.5M -$10.9B $349.2M -$574.9M
Cash From Investing -$925.1M -$2.1B -$12.2B -$944.8M -$726.9M
 
Dividends Paid (Ex Special Dividend) -$40.2M -$46.3M -$52.2M -$165.8M -$47.8M
Special Dividend Paid
Long-Term Debt Issued $189.3M $2.5B $9.8B $191.1M $1.5B
Long-Term Debt Repaid -$65.4M -$1.4B -$462.4M -$356.8M -$1.4B
Repurchase of Common Stock -$80.4M -$13.1M -- -- --
Other Financing Activities $160M $111.2M $757.6M $158.7M $80M
Cash From Financing $44.9M $1B $10.2B -$263.8M -$84.2M
 
Beginning Cash (CF) $2.9B $3.2B $3.4B $2.2B $2.1B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $284.1M -$1.8B -$853.2M -$79.2M $721.2M
Ending Cash (CF) $3.2B $1.3B $2.4B $2.1B $2.7B
 
Levered Free Cash Flow $725.3M $490.5M $501.5M $541.7M $1B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $202.8M -$179.8M $158.4M $271.3M $398.6M
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $328.2M $268.6M $145.4M $459.6M $376.4M
 
Capital Expenditures $188.6M $152.5M $160.5M $178.5M $125.4M
Cash Acquisitions -$37.4M $270.3M $67.7M $274.3M $650.9M
Cash From Investing -$435.1M -$506M -$90.7M -$94.7M $350M
 
Dividends Paid (Ex Special Dividend) -$1.3M $1.3M $3.6M -$47.5M -$1M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $828M -$156.8M $72.8M $242.6M $4M
Long-Term Debt Repaid -$1.1M -$98.5M -$239.1M -$346.8M -$67M
Repurchase of Common Stock -$339.8K -- -- -- --
Other Financing Activities -$711.8M -$4.6M -$906.4K -$1.2M $40.2M
Cash From Financing $72.9M -$282.5M -$246.1M -$188.7M -$67.1M
 
Beginning Cash (CF) $3B $2.2B $2.3B $2.2B $2.8B
Foreign Exchange Rate Adjustment -$18M $43.3M $119.3M $37.7M -$20.3M
Additions / Reductions -$34M -$584.7M -$191.3M $176.2M $659.3M
Ending Cash (CF) $3.1B $1.6B $2.1B $2.4B $3.4B
 
Levered Free Cash Flow $139.6M $116.1M -$15.1M $281.1M $251M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $560.3M $14.3B $851.7M $641.4M $1.3B
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $1.3B $1.2B $1.1B $1.5B $1.7B
 
Capital Expenditures $627.9M $792.1M $499.7M $615.6M $354.3M
Cash Acquisitions -$390.2M -$10.8B $165.4M -$641M $740.5M
Cash From Investing -$1.8B -$12.4B -$653.7M -$1.4B -$247.5M
 
Dividends Paid (Ex Special Dividend) -$32.5M -$51.7M -$57.6M -$156.3M -$88M
Special Dividend Paid
Long-Term Debt Issued $1.1B $10.9B $549.8M $1.4B $477M
Long-Term Debt Repaid -$44.6M -$1.7B -$459M -$1.1B -$863.8M
Repurchase of Common Stock -$15.1M -- -- -- --
Other Financing Activities $106.5M $511.8M $351.3M $122.9M $304.9M
Cash From Financing $924M $9.8B $267.7M $187.4M -$324.6M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $421.5M -$1.4B -$1.2B $320.8M $1.2B
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $647.5M $382.6M $650.1M $898.7M $1.4B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $387.6M $13.9B $404.2M $522.5M $1B
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $795.8M $749.8M $694.1M $1.1B $1.3B
 
Capital Expenditures $557.4M $619.3M $415M $442.9M $267.5M
Cash Acquisitions -$268.4M -$10.8B $322.3M -$667.9M $647.5M
Cash From Investing -$1.8B -$12.1B -$540.6M -$976.7M -$497.3M
 
Dividends Paid (Ex Special Dividend) -$46.2M -$51.5M -$57M -$47.5M -$87.8M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $1B $9.4B $116.4M $1.3B $334.1M
Long-Term Debt Repaid -$43M -$282.9M -$279.6M -$1B -$419.7M
Repurchase of Common Stock -$13M -- -- -- --
Other Financing Activities $78.9M $479.5M $73.2M $37.4M $262.3M
Cash From Financing $896.6M $9.7B -$240.8M $210.4M -$30M
 
Beginning Cash (CF) $9.8B $6B $7B $6.6B $7.9B
Foreign Exchange Rate Adjustment $34.5M -$45.6M $107M $5.8M $41.2M
Additions / Reductions -$110.7M $231.6M -$87.3M $312.8M $742.2M
Ending Cash (CF) $9.7B $6.1B $6.8B $6.9B $8.6B
 
Levered Free Cash Flow $238.5M $130.6M $279.2M $636.2M $1B

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock